Home

Drug firms will have to reveal full cost of new treatments to NICE

1999-02-11T00:00:00

Drug companies will be expected to produce evidence of 'the total cost to the NHS' of adopting new treatments under a proposed appraisal process for the National Institute for Clinical Excellence.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here